Iovance Biotherapeutics
IOVA
#6133
Rank
โ‚น84.52 B
Marketcap
โ‚น212.93
Share price
-3.28%
Change (1 day)
-57.94%
Change (1 year)

EPS for Iovance Biotherapeutics (IOVA)

EPS in 2025 (TTM): -โ‚น103.57

According to Iovance Biotherapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น108.27. In 2024 the company made an earnings per share (EPS) of -โ‚น117.29.

EPS history for Iovance Biotherapeutics from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น103.57-11.7%
2024-โ‚น117.29
2022-โ‚น223.7611.71%
2021-โ‚น200.30
2019-โ‚น142.5623.44%
2018-โ‚น115.49-9.22%
2017-โ‚น127.22-20.34%
2016-โ‚น159.70176.56%
2015-โ‚น57.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น5.41-95.00% Bahamas
NRC Health
NRC
โ‚น63.16-158.33%๐Ÿ‡บ๐Ÿ‡ธ USA